Immunohistochemical localization of chromogranin A and B in the endocrine cells of the alimentary tract of the green frog, Rana esculenta

1994 ◽  
Vol 277 (2) ◽  
pp. 341-349 ◽  
Author(s):  
Loredana D'Este ◽  
Roberto Buffa ◽  
Micaela Pelagi ◽  
Antonio G. Siccardi ◽  
Tindaro Renda

1994 ◽  
Vol 277 (2) ◽  
pp. 341-349 ◽  
Author(s):  
Loredana D'Este ◽  
Roberto Buffa ◽  
Micaela Pelagi ◽  
Antonio G. Siccardi ◽  
Tindaro Renda


1993 ◽  
Vol 273 (2) ◽  
pp. 335-344 ◽  
Author(s):  
Loredana D'Este ◽  
Roberto Buffa ◽  
Carlo Casu ◽  
Nadia Carboni ◽  
Micaela Pelagi ◽  
...  


1998 ◽  
Vol 35 (4) ◽  
pp. 312-315 ◽  
Author(s):  
J. C. Doss ◽  
A. Grone ◽  
C. C. Capen ◽  
T. J. Rosol

Chromogranin A is present in the secretory granules of endocrine cells and functions in hormone packaging, secretory granule stabilization, and regulation of hormone secretion. Immunohistochemical identification of chromogranin A can facilitate diagnosis of endocrine neoplasia. Normal and neoplastic canine tissues were stained immunohistochemically for chromogranin A. Staining of normal endocrine tissues demonstrated chromogranin A in chromaffin cells of the adrenal medulla, C cells of the thyroid gland, and pancreatic islets. The parathyroid chief cells and anterior pituitary stained lightly positive for chromogranin A. Pheochromocytomas (7/7), chemodectomas (5/7), islet cell carcinomas (2/6), pituitary adenomas (4/6), parathyroid adenomas (3/7), and a C-cell carcinoma (1/1) stained positive for chromogranin A. The data indicate that chromogranin A is widely distributed in canine endocrine tissues, and immunohistochemical staining of chromogranin A can be used to confirm the presence of secretory granules in endocrine tumors.



Life Sciences ◽  
2003 ◽  
Vol 73 (3) ◽  
pp. 265-274 ◽  
Author(s):  
Marina Paolucci


1999 ◽  
Vol 434 (1) ◽  
pp. 29-36 ◽  
Author(s):  
Stefano La Rosa ◽  
Silvia Uccella ◽  
Paola Billo ◽  
Carla Facco ◽  
Fausto Sessa ◽  
...  




2018 ◽  
Vol 103 (6) ◽  
pp. 2126-2135 ◽  
Author(s):  
Abu Saleh Md Moin ◽  
Megan Cory ◽  
Jennifer Choi ◽  
Allison Ong ◽  
Sangeeta Dhawan ◽  
...  

Abstract Context Chronic pancreatitis (CP) is characterized by inflammation, fibrosis, and a loss of pancreatic acinar cells, which can result in exocrine and eventually endocrine deficiency. Pancreatitis has been reported to induce formation of new endocrine cells (neogenesis) in mice. Our recent data have implicated chromogranin A–positive hormone-negative (CPHN) cells as potential evidence of neogenesis in humans. Objective We sought to establish if CPHN cells were more abundant in CP in humans. Design, Setting, and Participants We investigated the frequency and distribution of CPHN cells and the expression of the chemokine C-X-C motif ligand 10 (CXCL10) and its receptor chemokine C-X-C motif receptor 3 in pancreas of nondiabetic subjects with CP. Results CPHN cell frequency in islets was increased sevenfold in CP [2.1% ± 0.67% vs 0.35% ± 0.09% CPHN cells in islets, CP vs nonpancreatitis (NP), P < 0.01], as were the CPHN cells found as scattered cells in the exocrine areas (17.4 ± 2.9 vs 4.2 ± 0.6, CP vs NP, P < 0.001). Polyhormonal endocrine cells were also increased in CP (2.7 ± 1.2 vs 0.1 ± 0.04, CP vs NP, % of polyhormonal cells of total endocrine cells, P < 0.01), as was expression of CXCL10 in α and β cells. Conclusion There is increased islet endogenous expression of the inflammation marker CXCL10 in islets in the setting of nondiabetic CP and an increase in polyhormonal (insulin-glucagon expressing) cells. The increase in CPHN cells in CP, often in a lobular distribution, may indicate foci of attempted endocrine cell regeneration.



1985 ◽  
Vol 89 (6) ◽  
pp. 1366-1373 ◽  
Author(s):  
P. Facer ◽  
A.E. Bishop ◽  
R.V. Lloyd ◽  
B.S. Wilson ◽  
R.J. Hennessy ◽  
...  


2017 ◽  
Vol 50 (6) ◽  
pp. 149-158 ◽  
Author(s):  
Hirohumi Suzuki ◽  
Kentaro Yamada ◽  
Yasuhiro Matsuda ◽  
Minoru Onozuka ◽  
Toshiharu Yamamoto


Sign in / Sign up

Export Citation Format

Share Document